Medical Marijuana, Inc. Subsidiary HempMedsŪ Mexico to Showcase CBD Products at Expoweed Winter Cannabis Meeting in Mexico City

Friday, December 7, 2018 Drug News
Email Print This Page Comment bookmark
Font : A-A+

SAN DIEGO, Dec. 7, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis

company in the United States, announced today that subsidiary HempMedsŪ Mexico will be exhibiting at the Expoweed Winter Cannabis Meeting 2018 on Dec.
at Expo Reforma in Mexico City. This will be the first event of its kind where HempMedsŪ Mexico will be able to purvey their cannabidiol (CBD) hemp oil products onsite.

At the Expoweed Winter Cannabis Meeting, cannabis industry entrepreneurs will be able to secure supplies for their businesses, as well as specialized merchandise. The event will include two days of intense activity via conferences and workshops, dedicating Dec. 8 to the industrial uses of hemp and Dec. 9 to its medicinal uses.

"HempMeds Mexico is fortunate to have the ability to showcase and sell our CBD products that have just recently been approved for import from the U.S. at the Expoweed Winter Cannabis Meeting," said Medical Marijuana, Inc. CEO Dr. Stuart Titus. "Since the historic decision to allow the sale of CBD products in Mexico, our company has been at the forefront of the country's growing industry."

HempMedsŪ Mexico was the first company to receive a COFEPRIS federal government import permit for Real Scientific Hemp Oil-X™ (RSHO-X™), a cannabis product utilized for a medical indication. Not only is HempMedsŪ Mexico the first publicly traded company to sell their CBD products in the Mexican market, but they also have a storied history of partnering with local non-profit organizations to provide patients with quick access to their medication.

"The Expoweed Winter Cannabis Meeting will provide the perfect platform to educate the Mexican public about the health benefits of CBD," said HempMedsŪ Mexico President Raul Elizalde. "We believe that the country has moved in the right direction by sanctioning CBD importation and distribution and are thrilled to be a part of this movement."

About HempMedsŪ MexicoHempMedsŪ Mexico is a Mexico-based company that made history by being the first company to receive a COFEPRIS federal government import permit for the cannabis product RSHO-X™ for a medical indication. HempMedsŪ Mexico plans to work directly with the Mexican government to safely and legally provide access to CBD hemp oil products. For more information, please review the company's website at

About Medical Marijuana, Inc.We are a company of firstsŪ. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit

To see Medical Marijuana, Inc.'s corporate video, click here.

Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.'s shop.

FORWARD-LOOKING DISCLAIMER This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSUREThese statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.

LEGAL DISCLOSUREMedical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.


Andrew Hard, Chief Executive Officer CMW MediaP. 888-829-


Cision View original content:

SOURCE Medical Marijuana, Inc.

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store